Literature DB >> 7643551

Parathyroidectomy does not prevent the renal PTH/PTHrP receptor down-regulation in uremic rats.

P Ureña1, M Mannstadt, M Hruby, A Ferreira, F Schmitt, C Silve, R Ardaillou, B Lacour, A B Abou-Samra, G V Segre.   

Abstract

In a recent study we demonstrated that the PTH/PTHrP receptor (PTH-R) mRNA was markedly down-regulated in the remnant kidney of uremic rats with severe secondary hyperparathyroidism. Among the factors potentially implicated in this down-regulation, to date only PTH has been demonstrated to modulate PTH-R expression. Here, we examined the effect of thyroparathyroidectomy (TPTX) on the renal expression of PTH-R in rats with normal renal function or with chronic renal failure (CRF) induced by 5/6 nephrectomy. Four groups of rats were studied: control, TPTX, CRF, and CRF + TPTX. Moderate-degree renal failure was documented by mean (+/- SD) creatinine clearances (microliter/min/100 g body wt) of 259 +/- 40 and 212 +/- 45 in CRF and CRF + TPTX rats, compared with 646 +/- 123 and 511 +/- 156 in control and TPTX rats, respectively. Plasma phosphorus, calcitriol, and ionized calcium were significantly lower in CRF and CRF + TPTX than in control animals. Plasma ionized calcium and calcitriol were also lower in TPTX than in control rats. Plasma PTH levels (pg/ml) were increased in CRF rats (41.8 +/- 29.4), and markedly decreased in TPTX (10.1 +/- 7.8) and CRF + TPTX (8.0 +/- 3.8) rats compared with control rats (21.7 +/- 7.5). Northern blot analysis showed that the level of the steady-state PTH-R mRNA in the kidney of CRF and CRF + TPTX rats was markedly decreased compared with that of control rats, the ratios of PTH-R mRNA/beta-actin mRNA being 0.28 +/- 0.04 and 0.27 +/- 0.03 versus 0.54 +/- 0.05, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643551     DOI: 10.1038/ki.1995.248

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).

Authors:  Katherine Wesseling-Perry; G Chris Harkins; He-jing Wang; Robert Elashoff; Barbara Gales; Mara J Horwitz; Andrew F Stewart; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

3.  Ankle-brachial index and bone turnover in patients on dialysis.

Authors:  Gérard M London; Sylvain J Marchais; Alain P Guérin; Marie-Christine de Vernejoul
Journal:  J Am Soc Nephrol       Date:  2014-09-17       Impact factor: 10.121

4.  Expression of bone type 1 PTH receptor in rats with chronic renal failure.

Authors:  Michio Kuwahara; Seiji Inoshita; Yukiko Nakano; Yoshio Terada; Yoshiro Takano; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

Review 5.  Uremic Toxicity and Bone in CKD.

Authors:  Suguru Yamamoto; Masafumi Fukagawa
Journal:  J Nephrol       Date:  2017-06-01       Impact factor: 3.902

6.  Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure.

Authors:  Ely M Sebastian; Larry J Suva; Peter A Friedman
Journal:  Bone       Date:  2008-08-09       Impact factor: 4.398

7.  Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi).

Authors:  Michal Dranitzki Elhalel; Hanna Wald; Dvora Rubinger; Anka Gal-Moscovici; Makoto Inoue; Moshe Levi; Mordecai M Popovtzer
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

Review 8.  Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia.

Authors:  T B Drüeke
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 9.  TGF-Beta Signaling in Bone with Chronic Kidney Disease.

Authors:  Yoshiko Iwasaki; Hideyuki Yamato; Masafumi Fukagawa
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

10.  Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism.

Authors:  Tetsuhiko Sato; Yamato Kikkawa; Suguru Yamamoto; Yusuke Tanaka; Junichiro J Kazama; Yoshihiro Tominaga; Toshihiro Ichimori; Manabu Okada; Takahisa Hiramitsu; Masafumi Fukagawa
Journal:  Clin Kidney J       Date:  2019-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.